Welcome To NAVONE SPECIALTIES (OPC) Pvt Ltd
Navone Specialties (OPC) Pvt Ltd specializes in offering wide range of Latest & Advanced Pharma Intermediates & custom synthesis of New Molecules and have been catering to worldwide market since 1999.
Products offered are from approved manufacturing plant located at Maharashtra , India
Focus :
As India has emerged as an important destination for manufacturers worldwide. Skilled work-force, quality-conscious work culture, adherence to international standards, attractive economics, and above all, the desire to have inherent competitiveness globally are the key for this development. India has a vast pool of technological talent and quality consciousness.
Organizations that seek to source products and services from India are often overwhelmed by the vastness of land, diverse cultures and languages, and developing infrastructure. Such organizations need a reliable, trustworthy, and knowledgeable partner in India.
Company is focused on developing, manufacturing and marketing of a Latest & Advanced Pharma Intermediates & custom synthesis of New Molecules,
Vision :
To become a globally known pharmaceutical Intermediate export company in next couple of years, by providing a range of standard quality products at very competitive prices through continuing integration, research & development.
Strengths :Our main strength is "timely delivery of premium quality products at a very competitive price"
Regular Pharma Intermediate's :
| Pharma Intermediates ( Kgs to Tonnes Lot ) | |
| Product Name | CAS No |
| Ambroxol Intermediate | 50910-55-9 |
| 4-Acetamidobenzoic acid | 556-08-1 |
| Amlodipine Intermediate | 88150-62-3 / 14205-39-1 |
| 2- Acetyl thiophene | 88-15-3 |
| Apixaban Intermediate | 27143-07-3 / 603-15-4 |
| Adapalene Intermediate | 768-95-6 / 104224-63-7 |
| Bicalutamaide Intermediate | 90357-53-2 / 90357-51-0 |
| 4-Bromobenzaldehyde | 1122-91-4 |
| 4-(Bromomethyl)benzonitrile | 17201-43-3 |
| Bisoprolol Fumarate Intermediate | 123-08-0 |
| Bromo-OTBN (4-Bromomethyl 2-cyanobiphenyl) | 114772-54-2 |
| Benzamidine HCL | 1670-14-0 |
| Bilastine Intermediate | 1181267-33-3/1841081-72-8/32454-35-6 /826-55-1 |
| Bazedoxifene Intermediate | 35081-45-9 |
| Bempedoic acid Intermediate | 36635-61-7 |
| 5-Bromonicotinic Acid | 20826-04-4 |
| Benzil | 134-81-6 |
| 1-Bromoethyl acetate | 40258-78-4 |
| 2-Bromo-6-nitrophenol | 13073-25-1 |
| 4 Bromo Aniline | 106-40-1 |
| Bromopride Intermediate | 4093-34-9 |
| 4-Bromobenzonitrile | 623-00-7 |
| 2-Chloromethyl-4-Methoxy-3,5,Dimethylpyridine HCL | 95-25-0 |
| Clindamycin Intermediate | 603-35-0 |
| Citicoline Sodium Intermediate | 33818-15-4 |
| Clopidogrel Intermediate | 2856-63-5 |
| 2-chlorothiophenol | .6320-03-2 |
| 4 Chloro Benzophenone | 134-85-0 |
| 4-Chloro-4-hydroxybenzophenone | 42019-78-3 |
| 3-Chloro-4-(Pyridin-3-YL)-1,2,5-Thiadiazole | 131986-28-2 |
| Capecitabine Intermediate | 62211-93-2 |
| Chlorpromazine Intermediate | 92-39-7 |
| Cinnarzine Intermediate | 91-01-0 |
| Carvedilol Intermediate | 15128-52-6 |
| Canagliflozin Intermediate | 54811-38-0 |
| 4-Chloro benzhydryl piperazine | 303-26-4 |
| Dibutyltin(IV) oxide (DBTO) | 818-08-6 |
| 4,7 Dichloroquinoline | 86-98-6 |
| 2,4-Diaminophenoxyethanol dihydrochloride | 66422-95-5 |
| Dabigatran Intermediate | 103041-38-9 / 873-74-5 / 42288-26-6 / 873-74-5 |
| Diallyl Disulphide DAD’s | 2179-57-9 |
| Dapagliflozin intermediate | 461432-23-5 / 21739-92-4 |
| 3,5 di-Benzyloxy acetophenone | 28924-21-2 |
| 2,5-Dimethoxyphenylacetonitrile | 18086-24-3 |
| 3,5 Diiodosalicylic Acid | 609-99-4 |
| 4-Dimethylaminopyridine (DMAP) 98% | 1122-58-3 |
| 2,4-diamino-6-hydroxypyrimidine | 56-06-4 |
| 3,6-Dichloropyridazine | 141-30-0 |
| 3,8-dimethylacenaphthylene-1,2-dione | 146885-81-6 |
| 1,4-Dichlorobutane | 110-56-5 |
| Deferasirox Intermediate | 619-67-0 |
| 3,5-dihydroxy acetophenone | 51863-60-6 |
| 4-Dimethylaminobenzoic acid (DMABA) | 619-84-1 |
| Ethylhexyl salicylate | 118-60-5 |
| Ethylenedioxy)dimethanol (EDDM) | 3586-55-8 |
| Ethyl Bromo Acetate | 105-36-2 |
| Eletriptan Intermediate | 6163-58-2 |
| Etoricoxib Intermediate | 90536-66-6 / 10297-73-1 / 249561-98-6 |
| Furosemide Intermediate | 2736-23-4 / 50-84-0 |
| Fenofibrate Intermediate | 42019-78-3 |
| Fexofenadine Intermediate | 18755-52-7 / 83799-24-0 / 4635-59-0 /154477-54-0 |
| Fluconazole Intermediate | 86404-63-9 |
| Febuxostat Intermediate | 161797-99-5 / 160844-75-7 |
| Gliclazide Intermediate | 58108-05-7 |
| Gemcitabine Intermediate | 134790-39-9 |
| 4-Hydroxy Benzophenone | 1137-42-4 |
| 4-Hydroxy Carbazole | 52602-39-8 |
| Imatinib Intermediate | 152460-10-1/ 106261-49-8 |
| Ipratropium Bromide Intermediate | 710-11-2 |
| Itraconazole Intermediate | 67914-86-7 / 74852-61-2 |
| Ketoconazole Intermediate | 134071-44-6 / 154003-23-3 |
| Lopamidol Intermediate | 37441-29-5 |
| Lumefantrine Intermediate | 53221-07-1 / 69759-61-1 |
| Lacidipine Intermediate | 626-34-6 |
| Loratadine Intermediate | 29976-53-2 |
| Lansoprazole Intermediate | 37699-43-7 |
| Linagliptin Intermediate | 668270-12-0 / 3355-28-0 |
| Labetalol Intermediate | .6358-06-1 |
| Lamotrigine intermediate | 77668-42-9 |
| Losartan Potassium Intermediate | 124750-51-2 |
| 3 Methoxy phenol | 150-19-6 |
| Meta Phenoxy Benzyl Alcohol | 13826-35-2 |
| 3-Methyl Benzoic Acid ( Meta Toluic Acid) | 99-04-7 |
| Mirabegron Intermediate | 29968-78-3 |
| Meta Nitro Benzoic Acid | 121-92-6 |
| Moxifloxain Intermediate | 94695-52-0 |
| 2-Methoxyphenol | 90-05-1 |
| 5-Methylpyridin-3-amine | 3430-19-1 |
| Montelukast Intermediate | 152922-71-9 |
| Meloxicam intermediate | 7305-71-7 |
| Miconazole intermediate | 24155-42-8 |
| Mirtazapine intermediate | 61338-13-4 |
| Methyl 3-oxopentanoate | 30414-53-0 |
| 5 Nitroisophthalic Acid | 610-10-3 |
| Nintedanib Intermediate | 1160293-25-3 / 14192-26-8 |
| N Methyl-4-Piperidone(NM4P) | 1445-73-4 |
| N-Methyl-4-hydroxy piperidine | 106-52-5 |
| N-Methyl-4-hydroxy piperidine | 106-52-5 |
| Neostigmine Bromide Intermediate | 99-07-0 |
| N-Phenylanthranilic acid | 91-40-7 |
| Nepafenac Intermediate | 2835-77-0 / 22551-24-2 |
| Ondansetron Intermediate | 27387-31-1 |
| Omeprazole Intermediate | 86604-75-3 |
| Olopatadine Hydrochloride Base | 140462-76-6 |
| Pentoxifylline Intermediate | 10226-30-9 |
| Paroxetine Intermediate | 109887-53-8 |
| Phenyl Hydrazine Hydrochloride | 59-88-1 |
| Phenylepherine Intermediate | 121-71-1 |
| Pantoprazole Intermediate | 97963-62-7 / 72830-09-2 / 37052-78-1 |
| Pioglitazone intermediate | .5223-06-3 |
| Phenyl Isothiocyanate | 103-72-0 |
| Permethrin Intermediate | 13826-35-2 |
| Raloxifene Intermediate | 2632-13-5 |
| Ribavirin Intermediate | 611-94-9 |
| Rabeprazole Intermediate | 153259-31-5 / 583-39-1 |
| Rafoxanide Intermediate | 133-91-5 |
| Ropinirole Intermediate | 99-61-6 |
| Rotigotine Intermediate | 32940-15-1 |
| Risperidone Intermediate | 93076-03-0 |
| Sertraline Intermediate | 79560-19-3 |
| Sitagliptin Intermediate | 486460-32-6 / 2033-24-1 |
| Salmeterol intermediate | 3360-41-6 / 84163-13-3 |
| (S)-2-Chloro-1-(2,4-dichlorophenyl)ethanol | 126534-31-4 |
| Telmisartan Intermediate | 152628-02-9 |
| 1,1'Thiocarbonyldiimidazole | 6160-65-2 |
| Tetra benzyl pyrophosphate | 990-91-0 |
| Tri O Toluene Phosphine(ToTP) | 6163-58-2 |
| 3-(Trifluoromethyl)Acetophenone | 349-76-8 |
| 2-Thiophene carboxaldehyde | 98-03-3 |
| Tetrabenzyl pyrophosphate | 990-91-0 |
| 1,1,3,3-Tetramethyl guanidine | 30165-96-9 / 30315-46-9 |
| Timolol Maleate Intermediate | 80-70-6 |
| Tamsulosin Intermediate | 122-84-9 |
| Teneligliptin Intermediate | 401566-79-8 / 401564-36-1 |
| Ticagrelor Intermediate | 274693-27-5 |
| Tosyl Chloride Intermediate | 98-59-9 |
| Torsemide Intermediate | 504-24-5 |
| Trazodone Intermediate | 6969-71-7 |
| 1,1,3,3-Tetramethyl guanidine | 80-70-6 |
| Tributyl tin Oxide | 56-35-9 |
| Tizanidine Intermediate | 30536-19-7 |
| Vildagliptin Intermediate | 7531-52-4 / 207557-35-5 / 702-82-9 /665-66-7 |
| Valsartan Intermediate | 482577-59-3 / 114772-53-1 |
| For more information, kindly visit www.nivonindia.com ; www.navoneindia.com | |
| Impurity reference standards/working standards / custom synthesis/Nitrosamines & NDSRI | |
For more intermediates , please visit our website https://www.navoneindia.com/pharmaintermediates.html
Contact Us
Registered Office :
Navone Specialties (OPC) Pvt. Ltd
Vashi, New Mumbai,
Maharashtra
INDIA. Pin: 400703.
Mobile : +919323789882
Email :
info@navoneindia.com
navonepharma@yahoo.com
deepakkhanna938@hotmail.com